• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Chavant Capital Acquisition Corp. (Amendment)

    2/9/23 4:10:54 PM ET
    $CLAY
    Blank Checks
    Finance
    Get the next $CLAY alert in real time by email
    SC 13G/A 1 tm235960d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

      Under the Securities Exchange Act of 1934

     

    (Amendment No. 1)*

     

    Chavant Capital Acquisition Corp.

    (Name of Issuer)

     

    Ordinary Shares, par value $0.0001 per share 

    (Titles of Class of Securities)

     

    G2058L 103

    (CUSIP Number)

     

    December 31, 2022  

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)

    ¨ Rule 13d-1(c)

    x Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out of a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. G2058L 103

    Schedule 13G  

     

    1

    NAME OF REPORTING PERSON

     

    Chavant Capital Partners LLC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) o

    (b) o 

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    - 0 -

    6

    SHARED VOTING POWER

     

    1,580,513 (1)(2)

    7

    SOLE DISPOSITIVE POWER

     

    - 0 -

     

    8

    SHARED DISPOSITIVE POWER

     

    1,580,513 (1)(2)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,580,513 (1)(2)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨ 
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    53.5% (3)

    12

    TYPE OF REPORTING PERSON

     

    OO

               

    (1) The securities are held directly by Chavant Capital Partners LLC (the “Sponsor”) and indirectly beneficially owned by Jiong Ma, who is the sole member of Chavant Manager LLC, the manager of the Sponsor and has voting and dispositive power over the securities held directly by the Sponsor. As a result, Dr. Ma may be deemed to have beneficial ownership of the securities directly held by the Sponsor. Dr. Ma disclaims any beneficial ownership of the shares held by the Sponsor, except to the extent of her pecuniary interest therein.

     

    (2) The Sponsor owns 1,580,513 Ordinary Shares, par value $0.0001 per share (“Ordinary Shares”), of Chavant Capital Acquisition Corp. (the “Issuer”). Excludes certain Ordinary Shares which may be issuable upon exercise of certain private placement warrants owned or which may be acquired in the future. See Item 4.

     

    (3) Based on 2,953,033 Ordinary Shares outstanding as of December 5, 2022, as reported by the Issuer in its Proxy Statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission on December 16, 2022.   

     

    2

     

     

    CUSIP No. G2058L 103

    Schedule 13G  

     

    1

    NAME OF REPORTING PERSON

     

    Jiong Ma

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) o

    (b) o 

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    - 0 -

    6

    SHARED VOTING POWER

     

    1,580,513 (1)(2)

    7

    SOLE DISPOSITIVE POWER

     

    - 0 -

     

    8

    SHARED DISPOSITIVE POWER

     

    1,580,513 (1)(2)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,580,513 (1)(2)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨ 
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    53.5% (3)

    12

    TYPE OF REPORTING PERSON

     

    IN

               

    (1) The securities are held directly by the Sponsor and indirectly beneficially owned by Jiong Ma, who is the sole member of Chavant Manager LLC, the manager of, the Sponsor and has voting and dispositive power over the securities held directly by the Sponsor. As a result, Dr. Ma may be deemed to have beneficial ownership of the securities directly held by the Sponsor. Dr. Ma disclaims any beneficial ownership of the shares held by the Sponsor, except to the extent of her pecuniary interest therein.

     

    (2) The Sponsor owns 1,580,513 Ordinary Shares of the Issuer. Excludes certain Ordinary Shares which may be issuable upon exercise of certain private placement warrants owned or which may be acquired in the future. See Item 4.

     

    (3) Based on 2,953,033 Ordinary Shares outstanding as of December 5, 2022, as reported by the Issuer in its Proxy Statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission on December 16, 2022.   

     

    3

     

     

    Item 1(a). Name of Issuer:

     

    Chavant Capital Acquisition Corp.

     

    Item 1(b). Address of Issuer’s Principal Executive Offices:

     

    445 Park Avenue, 9th Floor

    New York, NY 10022

     

    Item 2(a). Name of Person Filing:

     

    This statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

     

    1. Chavant Capital Partners LLC

     

    2. Jiong Ma

     

    Item 2(b). Address of Principal Business Office or, if none, Residence:

     

    The principal business address of each of the Reporting Persons is as follows:

     

    445 Park Avenue, 9th Floor

    New York, NY 10022

     

    Item 2(c). Citizenship:

     

    See responses to Item 4 on each cover page.

     

    Item 2(d). Titles of Classes of Securities:

     

    Ordinary Shares, par value $0.0001 per share.

     

    Item 2(e). CUSIP Number:

     

    G2058L 103

     

    4

     

     

    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a(n):

     

    (a) ¨ Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o).
         
    (b) ¨ Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
         
    (c) ¨ Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
         
    (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
         
    (e) ¨ Investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
         
    (f) ¨ Employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
         
    (g) ¨ Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
         
    (h) ¨ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
         
    (i) ¨ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
         
    (j) ¨ Non-U.S. institution, in accordance with § 240.13d-1(b)(1)(ii)(J).
         
    (k) ¨ Group in accordance with §240.13d-1(b)(1)(ii)(K).
         
    If filing as a non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J), please specify the type of institution: ______________ .

     

    Item 4. Ownership

     

    (a) Amount beneficially owned:

     

    See responses to Item 9 on each cover page.

     

    (b) Percent of class:

     

    See responses to Item 11 on each cover page.

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote:

     

    See responses to Item 5 on each cover page.

     

    (ii) Shared power to vote or to direct the vote:

     

    See responses to Item 6 on each cover page.

     

    (iii) Sole power to dispose or to direct the disposition of:

     

    See responses to Item 7 on each cover page.

     

    (iv) Shared power to dispose or to direct the disposition of:

     

    See responses to Item 8 on each cover page.

     

    5

     

     

    Beneficial ownership information provided herein excludes (i) 2,794,332 Ordinary Shares issuable upon the exercise of 2,794,332 private placement warrants of the Issuer and (ii) Ordinary Shares underlying drawn and undrawn unsecured convertible promissory notes in the aggregate principal amount of $850,000 as of December 31, 2022, which amounts, to the extent drawn, may be converted upon the consummation of the Issuer’s initial business combination, at the option of the holder, into private placement warrants of the Issuer at a price of $1.00 per warrant. Each private placement warrant is exercisable to purchase one Ordinary Share at $11.50 per share, subject to adjustment, becomes exercisable 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. 

     

    Not Applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not Applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10. Certification.

     

    Not Applicable.

     

    6

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 9, 2023

     

      Chavant Capital Partners LLC 
      By: Chavant Manager LLC, its manager
         
      By: /s/ Jiong Ma
      Name: Jiong Ma
      Title: Sole Member
         
      /s/ Jiong Ma
      Jiong Ma

     

     

     

     

    EXHIBITS

     

    Exhibit

    Number

      Title
    1   Joint Filing Agreement, dated February 7, 2022, by and between Chavant Capital Partners LLC and Jiong Ma (filed as Exhibit 1 to the Schedule 13G filed on February 7, 2022 and incorporated herein by reference).

     

     

     

     

    Get the next $CLAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLAY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CLAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mobix Labs, Inc. Closes Business Combination with Chavant Capital Acquisition Corp., Becomes Publicly Traded

      IRVINE, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, today announced that its previously announced business combination with Chavant Capital Acquisition Corp. ("Chavant") (NASDAQ:CLAY) has closed, resulting in Mobix Labs becoming a publicly traded company. The business combination and all other proposals presented were approved at an extraordinary general meeting of Chavant shareholders held on December 18, 2023. In connection with the completion of the business combination,

      12/21/23 8:59:37 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Effectiveness of Registration Statement on Form S-4

      IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the "SEC") has declared effective the Registration Statement on Form S-4 (as amended, the "Registration Statement") filed by Chavant and relating to the previously announced proposed business combination between Mobix Labs and Chavant (the "Bus

      11/21/23 4:07:00 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Filing of Registration Statement on Form S-4 in Connection With Proposed Business Combination

      IRVINE, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), an innovative provider of next generation wireless mmWave 5G and connectivity solutions, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly-traded special purpose acquisition company, announced today the filing by Chavant with the U.S. Securities and Exchange Commission ("SEC") of a registration statement on Form S-4 (the "Registration Statement") on April 7, 2023, relating to the previously announced proposed business combination of Chavant and Mobix Labs. The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previousl

      4/10/23 8:00:00 AM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chavant Capital Acquisition Corp. (Amendment)

      SC 13G/A - MOBIX LABS, INC (0001855467) (Subject)

      2/9/24 7:26:55 AM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13D filed by Chavant Capital Acquisition Corp.

      SC 13D - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:21:14 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Chavant Capital Acquisition Corp.

      SC 13G - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:18:58 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chavant Capital Partners Llc disposed of 658,631 shares, bought $1,997,370 worth of shares (199,737 units at $10.00) and acquired 272,182 shares, decreasing direct ownership by 12% to 1,394,101 units (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 6:01:22 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Goerner Frederick C was granted 317,244 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:51:34 PM ET
      $CLAY
      Blank Checks
      Finance
    • Peterson James J was granted 2,404,845 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:50:44 PM ET
      $CLAY
      Blank Checks
      Finance
    • Carpou Bill was granted 73,752 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:48:00 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Leadership Updates

    Live Leadership Updates

    See more
    • LinKinVax Appoints Dr. Jiong Ma as Independent Board Member

      An international expert in the financing and growth of high tech businesses LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of Dr. Jiong Ma as independent board member. "As we enter the clinical stages of a number of drug candidates (HPV, Covid) resulting from our innovative vaccine platform, I am delighted to welcome Dr. Jiong Ma as an addition to our board. With a longstanding focus on the financing and growth of high tech businesses, her role will be to support us in our platform development strategy and to help us achieve our ambitions on a global scale. Dr. Jiong Ma benefits

      5/4/22 6:00:00 AM ET
      $AVXL
      $CLAY
      $SES
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Blank Checks
      Finance

    $CLAY
    SEC Filings

    See more
    • SEC Form NT 10-Q filed by Chavant Capital Acquisition Corp.

      NT 10-Q - MOBIX LABS, INC (0001855467) (Filer)

      2/15/24 4:52:22 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form 424B3 filed by Chavant Capital Acquisition Corp.

      424B3 - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 8:55:31 PM ET
      $CLAY
      Blank Checks
      Finance
    • Chavant Capital Acquisition Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits

      8-K - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 5:25:19 PM ET
      $CLAY
      Blank Checks
      Finance